Dow Up0.25% Nasdaq Up0.65%

Anika Therapeutics Inc. (ANIK)

-NasdaqGS
47.38 Up 0.85(1.83%) May 27, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015
Total Revenue 22,283   30,894   23,681   22,904  
Cost of Revenue5,425  6,290  5,176  5,274  
Gross Profit 16,858   24,604   18,506   17,629  
Operating Expenses
Research Development2,159  3,015  2,062  1,812  
Selling General and Administrative3,990  4,523  3,309  3,388  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 10,709   17,066   13,135   12,429  
Income from Continuing Operations
Total Other Income/Expenses Net72   -  34  24  
Earnings Before Interest And Taxes10,781  17,104  13,169  12,453  
Interest Expense -   -   -   -  
Income Before Tax10,781  17,104  13,169  12,453  
Income Tax Expense3,886  6,061  4,789  4,634  
Minority Interest -   -   -   -  
Net Income From Continuing Ops6,895  11,043  8,380  7,819  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 6,895   11,043   8,380   7,819  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 6,895   11,043   8,380   7,819  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.